Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-68.06M
↓ 83% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-37.28M
Historical baseline
PeriodValueYoY Change
TTM$-68.06M-33.7%
2024$-50.89M-216.6%
2023$-16.08M+29.2%
2022$-22.72M+20.7%
2021$-28.65M-